Pfizer’s Product Parachute? Firm Could See Rally Around New Approvals
You may also be interested in...
Congress has faith in Pfizer
Pfizer was the pharmaceutical sector stock most widely held by members of the House and Senate in 2005 and the second-most widely held stock overall by Congress, according to the Center for Responsive Politics. Pfizer's stock dropped nearly 15% in 2005 (1"The Pink Sheet" Jan. 30, 2006, p. 27). The review found 32 Democrats and 47 Republicans held shares in Pfizer. Other widely held pharma sector stocks include Johnson & Johnson (number 7 overall), Procter & Gamble (8), Merck (16) and Amgen (18)...
Congress has faith in Pfizer
Pfizer was the pharmaceutical sector stock most widely held by members of the House and Senate in 2005 and the second-most widely held stock overall by Congress, according to the Center for Responsive Politics. Pfizer's stock dropped nearly 15% in 2005 (1"The Pink Sheet" Jan. 30, 2006, p. 27). The review found 32 Democrats and 47 Republicans held shares in Pfizer. Other widely held pharma sector stocks include Johnson & Johnson (number 7 overall), Procter & Gamble (8), Merck (16) and Amgen (18)...
“One Pfizer” Restructuring Initiative Divides R&D And Sales Operations
Pfizer's latest corporate restructuring represents a shift away from its recent alignment of research & development and commercialization operations